About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Is Marin Software a Buy After Announcing an Agreement with Google?
Marin Software (MRIN) garnered investor attention as it recently entered into a revenue-sharing agreement with Alphabet’s (GOOGL) Google. However, it reported a loss in the second quarter. So, let’s find out if it is wise to bet on the stock now.
Should You Buy the Dip in Cleveland-Cliffs?
Steel company Cleveland-Cliffs’ (CLF) shares soared over the past few months as steel prices surged with rising demand. However, its shares plunged significantly since hitting its 52-week high of $26.51 on August 13, as China took measures to curb steel production. So, can the stock rebound on the back of its solid financials?
Up More Than 16% in the Last Month, is QuantumScape Still a Buy?
Shares of lithium battery developer QuantumScape (QS) soared last week on the news that it has partnered with a large automaker. However, is it wise to bet on the stock even though smart money interest has declined lately? Let’s find out.
Is Uber Stock a Buy After Raising its Outlook?
Uber’s (UBER) shares surged after the company raised its guidance for the upcoming quarters on September 21. However, can the stock continue to gain even though it continues to face increasing scrutiny? Let’s find out.
Is Corvus Pharmaceuticals a Good Healthcare Stock to Add to Your Portfolio?
Corvus Pharmaceuticals (CRVS) has been making headway on several developments in the immuno-oncology therapies space, which sent its shares soaring to their 52-week high of $9.54 on September 21. However, the stock’s price has since declined on profit-taking. So, let’s find out if it is wise to buy the dip in the stock now.
Should Blue Apron Holdings be in Your Portfolio?
The shares of Blue Apron Holdings (APRN), a well-known company in the meal kit industry, have surged in price over the past month. But will the company's decision to do away with its dual-class capital structure help the stock to continue advancing in the coming months as more restaurants reopen? Read on.
LoanDepot vs. CURO Group Holdings: Which Financial Stock is a Better Buy?
The Federal Reserve yesterday signaled that it might raise interest rates next year. And because a higher-rate environment aids the financial sector, LoanDepot (LDI) and CURO Group Holdings (CURO) should benefit. But which of these two stocks is a better buy now? Read more to find out.
Down More Than 8% in the Past Month, Should You Scoop Up Shares of Merck & Co?
Health care company Merck & Co’s (MRK) shares have declined more than 8% in price over the past month. However, the company made several advancements and reported impressive top-line growth across its major segments in the second quarter. So, is it wise to scoop up its shares now? Let’s find out.
Up Nearly 60% in the Past Month, is Rush Street Interactive Still a Buy?
Shares of online gambling company Rush Street Interactive (RSI) have surged nearly 60% in price over the past month as the company expands its market. However, can the stock continue to rally despite increasing competition in the burgeoning industry? Let’s find out.